Summit Therapeutics Inc. (SMMT)
NASDAQ · Healthcare
Summit Therapeutics Inc. Shareholder Equity 2019–2024
Summit Therapeutics Inc. annual shareholder equity history from 2019 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Summit Therapeutics Inc. shareholder equity as of December 31, 2024: 388.7M, a 400.37% increase year-over-year.
- Summit Therapeutics Inc. shareholder equity for 2024 were 388.7M, a 400.37% increase from 2023.
- Summit Therapeutics Inc. shareholder equity for 2023 were 77.7M, a 38.66% decrease from 2022.
- Summit Therapeutics Inc. shareholder equity for 2022 were 126.7M, a 52.07% increase from 2021.
- Summit Therapeutics Inc. shareholder equity for 2021 were 83.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Summit Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $389 |
| 2023 | $78 |
| 2022 | $127 |
| 2021 | $83 |
| 2020 | $79 |
| 2019 | $79 |
Summit Therapeutics Inc. Shareholder Equity — FAQ
Summit Therapeutics Inc. (SMMT) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SMMT's shareholder equity history?
The chart and table above show Summit Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.